Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Central District of California, captioned Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. - Investors have until January 26, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - Alexandria Real Estate is a real estate investment trust focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Group 3: Financial Performance and Stock Impact - Alexandria Real Estate reported lower-than-expected results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on October 27-28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for allegedly making materially false and misleading statements regarding the company's Long Island City property and its leasing value as a life-science destination during the specified Class Period from January 27, 2025, to October 27, 2025 [3][7]. Allegation Details - The lawsuit claims that the defendants provided overwhelmingly positive statements while concealing adverse facts about the true state of the Long Island City property [3]. - It is alleged that the company's claims regarding the leasing value of the LIC property were misleading and lacked a reasonable basis, particularly concerning the Megacampus™ strategy [3]. - As a result, the statements made by the defendants about the company's business, operations, and prospects were materially false and misleading throughout the Class Period [3]. Next Steps - Investors who purchased or acquired Alexandria shares and suffered losses are encouraged to contact the law firm for more information about their rights and potential claims [4][7]. - There is no cost or obligation for investors to inquire about their legal options [4]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various types of litigation, including securities and commercial litigation [5]. - The firm operates nationwide and handles cases in both federal and state courts [5].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Central District of California, captioned Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. - Investors have until January 26, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Group 3: Financial Performance and Stock Impact - Alexandria Real Estate reported lower-than-expected results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 between October 27 and October 28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6].

Core Viewpoint - A securities class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for failing to disclose material information during the class period, which has led to significant financial losses for investors [3]. Group 1: Lawsuit Details - Investors have until January 26, 2026, to file lead plaintiff applications in the lawsuit against Alexandria Real Estate Equities, Inc. for securities purchased between January 27, 2025, and October 27, 2025 [1]. - The lawsuit is pending in the United States District Court for the Central District of California [1]. - The case is titled Warren Hern v. Alexandria Real Estate Equities, Inc., et al., No. 25-cv-11319 [5]. Group 2: Financial Performance - On October 27, 2025, Alexandria disclosed third-quarter financial results for fiscal year 2025 that were below expectations, including a reduction in its FFO guidance for the full year due to lower occupancy rates and slower leasing activity [4]. - The company reported a real estate impairment charge of $323.9 million, with $206 million attributed to its LIC property [4]. Group 3: Market Reaction - Following the financial disclosure, Alexandria's share price fell from $77.87 per share on October 27, 2025, to $62.94 per share on October 28, 2025, marking a decline of approximately 19% in just one day [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Alexandria Real Estate Equities, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Alexandria Real Estate securities between January 27, 2025, and October 27, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 26, 2026 [3] - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][7] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [4] Group 3: Case Background - The lawsuit alleges that defendants provided misleading information regarding Alexandria Real Estate's expected revenue and funds from operations growth for the 2025 fiscal year, particularly concerning its Long Island City property [5][6] - Defendants reportedly made positive statements about leasing activity and occupancy stability while concealing adverse facts about the true state of the Long Island City property [6]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alexandria To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Alexandria between January 27, 2025 and October 27, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- ...

Core Viewpoint - Alexandria Real Estate Equities, Inc. has announced the tax treatment of its 2025 distributions, providing detailed information for stockholders regarding the classification of dividends and capital gains [1][2]. Distribution Details - The company has outlined the per-share distribution amounts for the year 2025, with a consistent distribution of $1.320000 per share for each quarter [1]. - The breakdown of the distribution includes ordinary dividends, capital gains, and return of capital, with specific amounts detailed for each category [1]. Tax Treatment - The tax treatment includes various classifications such as qualified dividends, Section 199A dividends, and unrecaptured Section 1250 gains, which are relevant for stockholders, particularly non-U.S. stockholders owning more than 10% of the company's stock [1][4]. - The total capital gains amount reflects gains from the disposition of U.S. real property interests, which is particularly relevant for certain stockholders [2][4]. Company Overview - Alexandria Real Estate Equities, Inc. is a leading life science REIT, established in 1994, and is recognized for its role in developing collaborative ecosystems in key life science innovation clusters across the U.S. [2]. - The company is listed on the S&P 500 and focuses on making a positive impact in the life science sector [2].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Central District of California, titled Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. - Investors have until January 26, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Group 3: Financial Performance and Stock Impact - Alexandria Real Estate reported lower-than-expected results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on October 27-28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million related to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. - Additional impairment charges may be recognized in Q4 2025, estimated between $0 to $685 million [6].

Core Viewpoint - Alexandria Real Estate Equities, Inc. (ARE) is facing financial challenges with expected declines in revenue and adjusted funds from operations (FFO) per share, attributed to occupancy pressures and slow re-leasing of spaces [2][6]. Financial Performance Expectations - Analysts forecast earnings per share (EPS) of $2.15 and revenue of approximately $742.6 million for the upcoming quarterly earnings release on January 26, 2026 [1]. - However, revenue is expected to slightly decline to $738.3 million, and adjusted FFO per share is projected to decrease by 10% year-over-year [2]. Occupancy and Leasing Challenges - ARE is experiencing occupancy pressures due to slow re-leasing of expiring spaces and filling vacancies, which contributed to missing the Zacks Consensus Estimate for adjusted FFO per share by 3.9% in the previous quarter [3][6]. - Despite these challenges, the company reported some positive leasing activity and rental rate growth [3]. Key Financial Metrics - The company has a negative price-to-earnings (P/E) ratio of -23.92, indicating negative earnings [4]. - The price-to-sales ratio stands at 3.35, and the enterprise value to sales ratio is 7.82, reflecting market valuation of the company's sales [4]. - The enterprise value to operating cash flow ratio is 17.02, showing investor willingness to pay for operating cash flow [4]. Financial Health Indicators - ARE's debt-to-equity ratio is 0.84, suggesting a moderate level of debt compared to equity [5]. - The current ratio is low at 0.27, indicating potential liquidity challenges in meeting short-term obligations [5]. - The earnings yield of -4.18% aligns with the negative earnings situation, further underscoring the company's financial hurdles [5].

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025 and October 27, 2025, both dates inclusive (the “Class Period”), of the important January 26, 2026 lead plaintiff deadline. SO WHAT: If you purchased Alexandria Real Estate securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs throu ...